Journal
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 130, Issue -, Pages S30-S33Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2023.02.009
Keywords
Tuberculosis; Diabetes; COVID-19; EndTB
Categories
Ask authors/readers for more resources
The COVID-19 pandemic has disrupted global tuberculosis control efforts, leading to undiagnosed TB cases. Additionally, COVID-19-induced diabetes mellitus is increasing, which is a risk factor for TB disease and worsens outcomes. This poses a significant challenge to TB control, especially in low- and middle-income countries with high TB burden.
The COVID-19 pandemic has significantly disrupted global tuberculosis (TB) control effort s. The mobilization of healthcare resources and personnel to combat the pandemic, and the nationwide lockdown measures resulted in an accumulation of a large number of undiagnosed TB cases. Exacerbating the situation, recent meta-analyses showed that COVID-19-induced diabetes mellitus (DM) is on the increase. DM is an established risk factor for TB disease and worsens outcomes. Patients with concurrent DM and TB had more lung cavitary lesions, and are more likely to fail TB treatment and suffer disease relapse. This may pose a significant challenge to TB control in low- and middle-income countries where a high TB burden is found. There is a need to step up the effort s to end the TB epidemic, which include increased screening for DM among patients with TB, optimizing glycemic control among patients with TB-DM, and intensifying TB-DM research to improve treatment outcomes for patients with TB-DM.& COPY; 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available